Oversea-Chinese Banking Corp (OCBC)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,536
| Closed | -$338K | – | 323 |
|
|
2025
Q1 | $338K | Buy |
+5,536
| New | +$338K | 0.01% | 311 |
|
|
2024
Q4 | – | Sell |
-22,143
| Closed | -$1.11M | – | 349 |
|
|
2024
Q3 | $1.11M | Buy |
22,143
+15,385
| +228% | +$771K | 0.03% | 219 |
|
|
2024
Q2 | $287K | Buy |
+6,758
| New | +$287K | 0.01% | 311 |
|
|
2024
Q1 | – | Sell |
-4,343
| Closed | -$223K | – | 323 |
|
|
2023
Q4 | $223K | Sell |
4,343
-969
| -18% | -$49.7K | 0.01% | 294 |
|
|
2023
Q3 | $308K | Sell |
5,312
-779
| -13% | -$45.2K | 0.01% | 303 |
|
|
2023
Q2 | $390K | Sell |
6,091
-1,889
| -24% | -$121K | 0.02% | 239 |
|
|
2023
Q1 | $553K | Buy |
7,980
+158
| +2% | +$11K | 0.03% | 205 |
|
|
2022
Q4 | $563K | Buy |
+7,822
| New | +$563K | 0.03% | 210 |
|